Valerie Speirs
   HOME

TheInfoList



OR:

Valerie Speirs is a Professor of
Molecular Oncology Molecular oncology is an interdisciplinary medical specialty at the interface of medicinal chemistry and oncology that refers to the investigation of the chemistry of cancer and tumors at the molecular scale. Also the development and applicatio ...
at the University of Aberdeen. Her research aims to identify biomarkers of breast cancer to inform diagnosis and treatment.


Education

Speirs studied zoology at the University of Aberdeen. She completed her graduate studies at the University of Glasgow. She worked with Ian Freshney on cell culture and became interested in how cell culture systems can be used to model disease.


Career and research

Speirs research investigates Cancer biology, Breast cancer and
Molecular pathology Molecular pathology is an emerging discipline within pathology which is focused in the study and diagnosis of disease through the examination of molecules within organs, tissues or bodily fluids. Molecular pathology shares some aspects of practice ...
. Speirs joined
The Hospital for Sick Children ''The'' () is a grammatical article in English, denoting persons or things already mentioned, under discussion, implied or otherwise presumed familiar to listeners, readers, or speakers. It is the definite article in English. ''The'' is the m ...
. Speirs worked at the University of Hull on the expression of oestrogen receptor mRNA. She looked at the role of the CGA gene in endocrine response. Speirs was a member of the
Breast Cancer Campaign Breast Cancer Campaign was a breast cancer research charity based in the United Kingdom. In 2015, Breast Cancer Campaign merged with another charity, Breakthrough Breast Cancer, to form the UK's largest breast cancer research charity - Breast C ...
Scientific Advisory Board in 2008. She joined the Irish Health Research Board in 2009. She served as principal investigator of the Leeds Breast Cancer Campaign Tissue Bank. She oversaw the launch of the tissue bank with the cancer research community in 2012. The tissue bank was a founding member of the
Breast Cancer Now Breast Cancer Now is a charity in the United Kingdom which was formed in 2015 by the merger of Breast Cancer Campaign and Breakthrough Breast Cancer. It is the United Kingdom's largest breast cancer charity. Its declared "Action Plan" is "by 205 ...
tissue bank. Speirs joined the University of Leeds in 2012. Since then she has been a member of the ''Sloane Project'' steering group, a five year study of 1,000 women. As lead of the St James's University Hospital Institute of Cancer & Pathology, Speirs looked to transfer lab-based molecular pathology techniques into the clinic for the identification of breast carcinoma in men and women. She serves on the advisory group of the National Cancer Research Institute biomarkers advisory group. She studies oestrogen receptor biology and endocrine resistant breast cancer. She has looked to identify the biomarkers for male breast cancer, finding that the
androgen receptor The androgen receptor (AR), also known as NR3C4 (nuclear receptor subfamily 3, group C, member 4), is a type of nuclear receptor that is activated by binding any of the androgenic hormones, including testosterone and dihydrotestosterone in th ...
biomarker had prognostic significance. She found that male breast cancers over-express eukaryotic initiation factors. She developed a series of resources to educate nurses in observing breast cancer. In 2016 Speirs launched the virtual resource Sharing Experimental Animal Resources: Coordinating Holdings in Breast Cancer (''SEARCHBreast''), a platform to share materials that are surplus to animal studies of breast cancer. The project was part of a NC3R grant to develop smart approaches to reduce animal use in science. The resources are available for the characterisation of tumour biomarkers and to investigate the effect of treatment. In 2018 Speirs joined the University of Aberdeen. She holds a visiting lectureship at the University of Leeds. She is a member of the Cellular Molecular Pathology initiative of National Cancer Research Institute. She is working with James Boyne at the University of Bradford on miRNA using blood and breast cancer tissues from the Breast Cancer Tissue Bank. They will investigate how endocrine disrupting agents modulate the activity of
fibroblast A fibroblast is a type of cell (biology), biological cell that synthesizes the extracellular matrix and collagen, produces the structural framework (Stroma (tissue), stroma) for animal Tissue (biology), tissues, and plays a critical role in wound ...
s in high and low mammographic density breast tissue. They use a 3D '' in vitro'' model of the human mammary gland. By identifying how oestrogen mimics effect human fibroblasts from areas of different breast density it will be possible to identify how the drives breast cancer development. She has published extensively on breast cancer and has a h-index of over 40. She is associate editor for ''
BMC Cancer BMC may refer to: Business and organizations * Beard Miller Company, a US public accounting firm * BioMed Central, a UK-based scientific publisher * BMC Software, an American business service management software vendor * BMC Switzerland, a Swiss b ...
''.


Awards and honours

Speirs was elected a Fellow of the Royal College of Pathologists (FRCPath) in 2007.


References

{{DEFAULTSORT:Speirs, Valerie Year of birth missing (living people) Living people Cancer researchers Academics of the University of Aberdeen Academics of the University of Leeds Alumni of the University of Aberdeen Alumni of the University of Glasgow